RYVERZA
LIVE

Serial Number

79312656

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RYVERZA Trademark

Serial Number: 79312656 • Registration: 6564858

RYVERZA is a trademark filed by NOVARTIS AG on March 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 17, 2021

Registration Date

November 23, 2021

Published for Opposition

September 7, 2021

Cancellation Date

May 22, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 16, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Dec 16, 2024 DETH
NOTIFICATION PROCESSED BY IB
Feb 5, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 18, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 23, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2021 CNSA
ASSIGNED TO EXAMINER
Jul 31, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Jun 15, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 10, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 3, 2021 SDRC